Zenas BioPharma, Inc. (ZBIO)
18.49
+0.88
(+5.00%)
USD |
NASDAQ |
Jun 09, 16:00
18.49
0.00 (0.00%)
After-Hours: 20:00
Zenas BioPharma SG&A Expense (Quarterly) : 16.91M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.80M |
| Gilead Sciences, Inc. | 1.451B |
| Nkarta, Inc. | 5.888M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |